"The opportunity to change even one person's health journey for the better is so powerful. To build something - together with a team of people with the same passion - that could help millions of people and positively impact the trajectories of their lives is worthy of a single-minded obsession. That's why I am here at Accolade."
Rajeev Singh is the CEO and chair of the board of directors at Accolade (Nasdaq: ACCD). Singh joined Accolade as CEO in November of 2015. Under Singh’s leadership, Accolade become a publicly traded company in 2020, and integrated four companies in over $1 billion in acquisitions. Accolade launched a new category of healthcare, Personalized Healthcare, in 2022.
Prior to joining Accolade, Singh co-founded Concur, the global leader in travel and expense management. Concur went public (Nasdaq: CNQR) in 1998 and grew to more than $800 million in revenue, over 4,000 employees and more than 25,000 customers before being acquired by SAP AG for $8.3 billion in 2014. Singh was president and chief operating officer as well as a member of the board of directors at Concur.
Singh serves on the board of Amperity, an intelligent customer data platform, based in Seattle. He graduated with a Bachelor of Science in Engineering from Western Michigan University.